|
|
1404
|
|
ارائه دهنده
|
دوشنبه 8:00 تا 9:00
|
عنوان
|
|
دکتر سمیه کریمیان
|
1404/07/27
|
Three Minds, One Metal–Organic Frameworks: From Discovery to Application
|
|
دکتر پوست فروش
|
1404/02/01
|
AI, my clever Assistant
|
|
دکتر موسوی
|
1404/03/05
|
The Dance of Life: Human Evolution from Single Cells
|
|
دکتر جعفری
|
1404/03/19
|
The story of cancer with a happy ending!
|
|
دکتر میرخانی
|
1404/05/15
|
Drug Repurposing
|
|
|
|
1403
|
|
ارائه دهنده
|
(دوشنبه 8:00 تا 9:00)
|
عنوان
|
|
دکتر کریمیان
|
1403/11/08
|
The Role of Artificial Intelligence in Chemistry and Medicinal Chemistry
|
|
دکتر امیدرضا فیروزی
|
1403/02/03
|
Evolutionary dynamics of cancer (Part II)
|
|
دکتر مردانه
|
1403/03/29
|
Design, Synthesis, Biological Evaluation and Structure-Activity Relationships of new derivatives of 1,4-naphthoquinone connected to Triazole and iminochromene derivatives bearing Carbonyl Hydrazone groups as potential agents for cancer treatment
|
|
دکتر حسنی
|
1403/04/04
|
Anticancer effect of combination therapy of Olaparib and chemotherapy drugs
|
|
دکتر امیررضا جاسبی
|
1403/08/14
|
Structure Elucidation of Natural Products from Classic to Modern approaches
|
|
دکتر جعفری
|
1403/09/12
|
Piecing Together the Research Puzzle: an introduction to systematic review and meta-analysis
|
|
|
|
1402
|
|
ارائه دهنده
|
(دوشنبه 8:00 تا 9:00)
|
عنوان
|
|
دکتر امیر رضا جاسبی
|
1402/02/25
|
How to Write and Publish a Scientific Paper: Part III, Ethics and legal Points, After Submission Events
|
|
دکتر مردانه
|
1402/03/22
|
Design, Synthesis, Biological Evaluation and Structure-Activity Relationships of new derivatives of 1,4-naphthoquinone connected to Triazole and iminochromene derivatives bearing Carbonyl Hydrazone groups as potential agents for cancer treatment
|
|
دکتر نظری
|
1402/07/10
|
Met receptor tyrosine kinase inhibitors reverse anticancer drug resistance in ABCB1 and ABCG2 overexpressing cells
|
|
دکتر موسوی
|
24/7/1402
|
Targeting DNA damage response in pancreatic cancer
|
|
دکتر جعفری
|
1402/08/08
|
بررسی تاریخچه و چالش های اخلاقی تبلیغات شرکت های دارویی در اپیدمی اوپیوییدها
|
|
دکترهمتی نژاد
|
1402/09/06
|
Miniaturized optical nose/tongue, analytical devices for health monitoring
|
|
دکتر کریمیان
|
1402/08/29
|
Tyrosinase Inhibitors as Skin-lightening Agents
|
|
دکتر پوست فروش
|
1402/10/18
|
The role of Machine learning in personalized combination therapy
|
|
دکتر جعفری
|
1402/010/25
|
Optimizing Research Productivity: The Strategic Application of Artificial Intelligence as a Research Assistant
|
|
دکتر میرخانی
|
1402/11/02
|
Why Research?
(parts I and II)
|
|
آقای دکتر فیروزی
|
1402/12/7
|
Evolutionary dynamics of cancer (Part I)
|
|
|
|
1401
|
|
ارائه دهنده
|
(دوشنبه 8:00 تا 9:00)
|
عنوان
|
|
رویا فیروزی
|
1401/05/24
|
Assessment of combination of MET inhibitors and DNA damaging agents on pancreatic cancer cells
|
|
دکتر ادراکی
|
1401/06/07
|
Hybridization of 4-piperidine-triazoles:Selective targeting of cancer cells
|
|
دکتر مردانه
|
1401/07/11
|
Design, Synthesis, Biological Evaluation and Structure-Activity Relationships of New Derivatives of 1,4-naphthoquinone connected to Triazole or Carbonyl Hydrazone groups as Potential agent for cancer Treatment
|
|
دکتر محبوبی فر
|
1401/09/14
|
Application of chemometrics in drug discovery and recent advances in essential oil’s encapsulation studies
|
|
دکتر نظری
|
1401/09/21
|
Assessment of combination of MET inhibitors and DNA damaging agents on multidrug resistance and DNA damage response
|
|
دکتر موسوی
|
1401/10/12
|
cancer biomarkers research in the precision medicine era
|
|
دکتر میرخانی
|
1401/10/26
|
Incretin hormone mimetic for treatment of type-2 diabetes
|
|
نیلوفر مهیمنیان
|
1401/11/10
|
Antidiabetic effects of marine algae
|
|
دکتر امیررضا جاسبی
|
1401/11/24
|
How to Write and Publish a Scientific Paper: Part III, Ethics and legal Points, After Submission Events
|
|
دکتر فیروزی
|
1401/12/08
|
Personalized Medicine
|
|
|
|
1400
|
|
ارائه دهنده
|
دوشنبه 8:00 تا 9:00
|
عنوان
|
|
دکتر ادراکی
|
1400/02/13
|
HDAC6 as privileged target in drug discovery
|
|
دکتر خوشنویس زاده
|
1400/03/10
|
Approach in improving potency and selectivity of kinase inhibitors: allosteric kinase inhibitors
|
|
دکتر نظری
|
1400/03/17
|
Cardiorenal protection of SGLT2 inhibitors in the treatment of type 2 diabetes
|
|
مردانه
|
1400/03/31
|
Targeting Receptor Tyrosine Kinase MET in Cancer: Small Molecule Inhibitors and Clinical Progress
|
|
دکتر فیروزی
|
1400/04/28
|
Evidence-based medicine part II (Different types of clinical studies)
|
|
طاهره دامغانی
|
1400/06/01
|
"Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer."
|
|
دکتر پیرهادی
|
1400/06/15
|
Drug design strategies to avoid resistance.
|
|
دکتر محبوبی فر
|
1400/06/29
|
Assessments of natural compounds bioactivity based on chemical fingerprints and chemomeric methods.
|
|
مهیمنیان
|
1400/07/12
|
Screening of the alfa-glucosidase inhibitory effects of brown algae Sargassum swartzii and Padina tetrastromaticafrom Persina gulf shores.
|
|
دکتر البرز
|
1400/07/26
|
Structure Elucidation and Cytotoxic Bioassay ofAxinellasponge-associated Bacteria Strain WAK9 of the Persian Gulf.
|
|
دکتر میرخانی
|
1400/08/10
|
The Centenary of Insulin.
|
|
دکتر موسو ی
|
1400/08/24
|
Combination cancer therapies
|
|
دکتر جاسبی
|
1400/09/08
|
NMR Guided purification of natural products, Salvia macroclymis as an example
|
|
|
|
1399
|
|
ارائه دهنده
|
تاریخ
(دوشنبه 8:00 تا 9:00)
|
عنوان
|
|
دکتر فیروز ی
|
1399/07/07
|
Evidence based medicine
|
|
دکتر پیرهادی
|
1399/07/28
|
Application of virtual screening in drug discovery
|
|
دکتر محبوبی فر
|
1399/08/19
|
Application of virtual screening in drug discovery oil against Aspergillus flavus for aflatoxin reduction
|
|
مهیمنیان
|
1399/08/26
|
|
|
دکتر حقیقی جو
|
1399/09/03
|
|
|
دکتر البرز
|
1399/09/17
|
|
|
دکتر میرخانی
|
1399/10/01
|
Importance of Chirality in Pharmacology
|
|
دکتر موسو ی
|
1399/10/15
|
Biological rationale for combination therapy in cancer
|
|
دکتر جاسبی
|
1399/10/30
|
|
|
دکتر دامغانی
|
1399/11/13
|
|
|
مطهره مرتضوی
|
1399/11/27
|
Targeted therapy of pancreatic cancer
|
|
دکتر خوشنویس زاده
|
1399/12/04
|
|
|
دکتر ادراکی
|
1399/12/18
|
|
|
|
|
1397
|
|
ارائه دهنده
|
عنوان
|
|
دکتر امین علی آبادی
|
ایمیونوتراپی سرطان
|
|
دکتر سید حسین میرخانی
|
تازه های دیابت
|
|
مهندس مهدی زارع
|
اصول کار و ایمنی در آزمایشگاه میکروبی
|
|
دکتر امیدرضا فیروزی
|
اصول اخلاقی در نشر
|
|
دکتر امیر رضا جاسبی
|
نکاتی در باره نگارش و ارسال مقالات علمی
|
|
دکتر زهرا حقیقی جو
|
به عنوان هدف درمانی مشترک در درمان سرطان و دیابت PTPB1 نقش
|
|
دکتر مریم البرز
|
Synthesis of Novel Benzothiazolo β-Lactam Hybrids and the Use of Multicomponent Reactions (MCRs) in the Synthesis of Phthalazine, Imidazol and Phenylthiazole-Pyrazole β-Lactam Hybrids and Their Biological Investigation
|
|
دکتر سمیه پیرهادی
|
Molecular modeling: a powerful tool for drug discovery
|
|
دکتر فاطمه موسوی
|
نقش کینازها به عنوان تارگت های مهم در درمان سرطان
|
|
دکتر مهرداد عسکریان
|
سرقت ادبی
|
|
سمیه زارع
|
جدا سازی و شناسایی ترکیبات موثره کیاهان جنس سالویا
|
|
طاهره دامغانی
|
Design, Synthesis, Biological Evaluation and Structure-Activity Relationships of Novel Derivatives of Imidazopyridine Hydrazone connected to Phenoxy Triazole groups as c-Met kinase Inhibitors Effective in Cancer Therapy
|
|
